Day TwoWednesday, 25 March 2026 - Western European Summer Time (WEST)

The biopharmaceutical sector is experiencing a transformative market recalibration, creating unique windows of opportunity for agile industry players. Our distinguished panel brings together visionary leaders who are successfully navigating this evolution with innovative approaches and strategic foresight. As the market redefines value metrics, forward-thinking companies are pioneering creative capital strategies while investors discover promising alternative pathways to exceptional returns. Simultaneously, pharmaceutical companies are leveraging these dynamic conditions to forge groundbreaking partnerships and strategic acquisitions that promise to reshape the industry landscape. This energizing discussion showcases how today's market challenges are catalyzing innovation, strategic realignment, and the emergence of tomorrow's industry leaders poised for remarkable growth and success.

• How can biotech companies adjust their valuation expectations to attract investors in today’s market?
• What strategies are investors employing to navigate the lack of M&A and value-creating catalysts?
• How can large pharma leverage the current market conditions to identify undervalued assets or partnerships?